Equity Medical

Clinical research site in New York, New York · 11 WALL ST, NEW YORK, NY 10005-1905 · (212) 656-5407 · Website

Part of Equity Medical

As of July 2026, 12 paid clinical trials are recruiting at Equity Medical in New York, New York. Active studies at this site cover conditions such as Chronic Inducible Urticaria, Cold Urticaria and Cold-Induced Urticaria. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Equity Medical (12)

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

for Chronic Inducible Urticaria

26 locations incl. Birmingham

Sponsor: Celldex Therapeutics

Sex: All·Age: 18+

Code: NCT07266402·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for Atopic Dermatitis

66 locations incl. Birmingham

Sponsor: AbbVie

Sex: All·Age: 18 - 63

Code: NCT06389136·Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for NonSegmental Vitiligo

69 locations incl. Birmingham

Sponsor: Incyte Corporation

Sex: All·Age: 2 - 11

Code: NCT06548360·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata

for Alopecia Areata

39 locations incl. Chula Vista

Sponsor: AbbVie

Sex: All·Age: 12 - 63

Code: NCT06012240·Phase 3·Recruiting·Listed Aug 2023

Apply to this trial

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

for Allergy

56 locations incl. Birmingham

Sponsor: DBV Technologies

Sex: All·Age: 1 - 3

Code: NCT07003919·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

for Dermatitis Atopic

43 locations incl. Birmingham

Sponsor: Sanofi

Sex: All·Age: 12+

Code: NCT06241118·Phase 3·Recruiting·Listed Feb 2024

Apply to this trial

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

for Psoriasis

40 locations incl. Phoenix

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06857942·Phase 4·Recruiting·Listed Mar 2025

Apply to this trial

A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

for Hidradenitis Suppurativa

16 locations incl. Scottsdale

Sponsor: Sanofi

Sex: All·Age: 18+

Code: NCT07225569·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

for Asthma

17 locations incl. Tempe

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 75

Code: NCT07219173·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

for Hidradenitis Suppurativa

22 locations incl. Phoenix

Sponsor: Incyte Corporation

Sex: All·Age: 12 - 75

Code: NCT07049575·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC)

for Nodular Basal Cell Carcinoma

2 locations incl. Bowling Green

Sponsor: Feldan Therapeutics

Sex: All·Age: 18 - 85

Code: NCT07670858·Phase 1·Recruiting·Listed Jun 26, 2026

Apply to this trial

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

for Chronic Obstructive Pulmonary Disease

3 locations incl. Bowling Green

Sponsor: Bambusa Therapeutics

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT06944925·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial

More research sites in New York

Memorial Sloan Kettering Cancer Center (460 trials)
NYU Langone Health (304 trials)
Icahn School of Medicine at Mount Sinai (257 trials)
Columbia University Irving Medical Center (178 trials)
Memorial Sloan Kettering Cancer Center (All Protocol Activities) (157 trials)
Weill Cornell Medicine (134 trials)
Mount Sinai Hospital (121 trials)
Columbia University Medical Center (119 trials)
Columbia University (105 trials)
Hospital for Special Surgery (66 trials)

Explore more

Paid clinical trials in New York, NY · New York clinical trials